Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

Published:2019-08-23 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Biber Knut,Bhattacharya Anindya,Campbell Brian M.,Piro Justin R.,Rohe Michael,Staal Roland G.W.,Talanian Robert V.,Möller Thomas

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference214 articles.

1. The promise and peril of chemical probes;Arrowsmith;Nat. Chem. Biol.,2015

2. Dose-escalation study of ICA-17043 in patients with sickle cell disease;Ataga;Pharmacotherapy,2006

3. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia;Ataga;Blood,2008

4. Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia;Ataga;Expert Opin. Investig. Drugs,2009

5. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2);Atagi;J. Biol. Chem.,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision drug delivery to the central nervous system using engineered nanoparticles;Nature Reviews Materials;2024-06-25

2. Suppression of HIV-TAT and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters;Journal of NeuroVirology;2024-06-17

3. Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?;Diseases;2024-05-22

4. The reduction of microglial efferocytosis is concomitant with depressive-like behavior in CUMS-treated mice;Journal of Affective Disorders;2024-05

5. Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics;Journal of Advanced Research;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3